5 Spam-Free Article(s) Found
Mar 18, 2019 - Regeneron (REGN) and partner Sanofi receives approval in Europe for the label expansion of Praluent to reduce cardiovascular (CV) risk in adults with established atherosclerotic CV disease.
Mar 15, 2019 - Roche (RHHBY) gets EC approval for the label expansion of its legacy RA drug, MabThera for pemphigus vulgaris.
Mar 15, 2019 - BMO Capital Markets issues rating change for AMGN
Mar 15, 2019 - Agilent (NYSE:A) initiated with Buy rating and $92 (14% upside) price target at UBS.Amgen (NASDAQ:AMGN) initiated with Outperform rating and $228 (21% upside) at BMO.Fluidigm (NASDAQ:FLDM) initiated w
Mar 14, 2019 - Roche (RHHBY) gets approval from European Commission for a label expansion of hemophilia drug, Hemlibra.